Search Results - "Titong, Allison"
-
1
Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
Published in Scientific reports (20-10-2020)“…SARS-CoV-2 is a newly emergent coronavirus, which has adversely impacted human health and has led to the COVID-19 pandemic. There is an unmet need to develop…”
Get full text
Journal Article -
2
First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants
Published in Scientific reports (09-03-2022)“…SARS-CoV-2 and its variants have persisted in this ongoing COVID-19 pandemic. While the vaccines have greatly reduced the COVID-19 cases, hospitalizations, and…”
Get full text
Journal Article -
3
Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity
Published in Emerging microbes & infections (01-01-2020)“…Coronaviruses cause severe human viral diseases including SARS, MERS and COVID-19. Most recently SARS-CoV-2 virus (causing COVID-19) has led to a pandemic with…”
Get full text
Journal Article -
4
Author Correction: Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
Published in Scientific reports (17-02-2021)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
5
Fc-competent multispecific PDL-1/TIGIT/LAG-3 antibodies potentiate superior anti-tumor T cell response
Published in Scientific reports (18-06-2023)“…The landscape of current cancer immunotherapy is dominated by antibodies targeting PD-1/PD-L1 and CTLA-4 that have transformed cancer therapy, yet their…”
Get full text
Journal Article -
6
Replication-inducible vaccinia virus vectors with enhanced safety in vivo
Published in PloS one (02-04-2020)“…Vaccinia virus (VACV) has been used extensively as the vaccine against smallpox and as a viral vector for the development of recombinant vaccines and cancer…”
Get full text
Journal Article -
7
A vaccinia virus renaissance: New vaccine and immunotherapeutic uses after smallpox eradication
Published in Human vaccines & immunotherapeutics (01-07-2012)“…In 1796, Edward Jenner introduced the concept of vaccination with cowpox virus, an Orthopoxvirus within the family Poxviridae that elicits cross protective…”
Get full text
Journal Article -
8
Safety mechanism assisted by the repressor of tetracycline (SMART) vaccinia virus vectors for vaccines and therapeutics
Published in Proceedings of the National Academy of Sciences - PNAS (17-09-2013)“…Replication-competent viruses, such as Vaccinia virus (VACV), are powerful tools for the development of oncolytic viral therapies and elicit superior immune…”
Get full text
Journal Article -
9
Abstract LB068: A novel CD20/CD3 T cell engager designed from Rituximab targeting CD20+ cancer with multiple mechanisms
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Background Bispecific T cell engaging antibodies (TEAs) with one arm targeting a cancer antigen and another arm binding to CD3 have demonstrated impressive…”
Get full text
Journal Article -
10
Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication
Published in Virus research (06-03-2014)“…•Uncontrolled replication of vaccinia virus vectors can lead to complications.•We placed early transcription factor genes under the control of tet operon…”
Get full text
Journal Article -
11
Biological activity validation of a computationally designed Rituximab/CD3 T cell engager targeting CD20+ cancers with multiple mechanisms of action
Published in Antibody therapeutics (01-10-2021)“…Abstract Background Bispecific T cell engaging antibodies (TEAs) with one arm targeting a cancer antigen and another arm binding to CD3 have demonstrated…”
Get full text
Journal Article -
12
Development of Repressible Systems to Control Gene Expression in Vaccinia Virus
Published 01-01-2012“…Two vaccinia virus (VACV) expression systems that contain elements from the lactose (lac) and the tetracycline (tet) operons of E. coli were developed to…”
Get full text
Dissertation